GANX Competitors & Alternatives
Compare Gain Therapeutics Inc with similar stocks in the same industry
Biotechnology
GANX
Main Stock$1.08
Tradestie Score
57
Market Cap
$65.43M
Revenue Growth
-1.0%
Analyst Upside
+566.7%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRZN
Surrozen, Inc. Common
|
$31.67
|
$117.07M | - | 30 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$4.81
|
$114.01M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$30.62
|
$110.20M | - | 41 | Compare |
|
COYA
Coya Therapeutics, Inc. Common Stock
|
$3.27
|
$97.84M | - | 57 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.55
|
$97.42M | - | 50 | Compare |
|
HOWL
Werewolf Therapeutics, Inc. Common Stock
|
$0.98
|
$89.17M | - | 45 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.22
|
$84.52M | - | 40 | Compare |
|
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
|
$0.67
|
$83.60M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.07
|
$67.94M | - | 52 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$0.82
|
$10.26M | - | 46 | Compare |
More GANX Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry